Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions

Published:2023-02-01 Issue:2 Volume:19 Page:75-90
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Combarel David¹²,Tran Julie¹^ORCID,Delahousse Julia¹,Vassal Gilles³,Paci Angelo¹²

Affiliation:

1. Service de Pharmacologie, Département de biologie et pathologie médicale, Gustave Roussy, Université Paris-Saclay, Villejuif, France

2. Université Paris-Saclay, Faculté de Pharmacie, Université Paris-Saclay, Chatenay-Malabry, France

3. Gustave Roussy Comprehensive Cancer Center, University Paris-Saclay, Villejuif, France

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2023.2192924

Reference171 articles.

1. NDA FDA. 20-954 busulfex (busulfan) injection.

2. Crosslinking of DNA by busulfan Formation of diguanyl derivatives

3. From old alkylating agents to new minor groove binders

4. Mechanisms of DNA–protein crosslink repair

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients;Therapeutic Drug Monitoring;2024-06-14

2. Riluzole reverses blood-testis barrier loss to rescue chemotherapy-induced male infertility by binding to TRPC;2024-04-29

3. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT;Transplantation and Cellular Therapy;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3